regulatory
confidence high
sentiment negative
materiality 0.70
Entero Therapeutics receives Nasdaq non-compliance notice for late Form 10-Q filing
GridAI Technologies Corp.
- Nasdaq notice on Aug 21, 2024, for failure to timely file Q2 2024 Form 10-Q.
- Company has 60 days (until Oct 21, 2024) to submit compliance plan; possible extension to Feb 17, 2025.
- Forvis Mazars resigned as auditor on Aug 9, 2024; company seeking new independent accounting firm.
- Notice has no immediate effect on Nasdaq listing, but delisting risk if compliance not regained.